To display releases by year, please select a year below and click Filter.
August 23, 2023
Whitman-Walker Institute, Cancer Support Community and GRAIL Collaborate On Research Aimed at Advancing Health Equity in Cancer Screening and Care through Multi-Cancer Early Detection
View Press Release
June 20, 2023
The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population
View Press Release
June 3, 2023
GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting
View Press Release
June 3, 2023
New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing
View Press Release
June 1, 2023
GRAIL and University of Oxford to Present Results From First Prospective Study of Multi-Cancer Early Detection in a Symptomatic Patient Population at 2023 ASCO Annual Meeting
View Press Release
May 22, 2023
Grail to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting
View Press Release
April 19, 2023
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
View Press Release
April 18, 2023
FirstHealth of the Carolinas to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Blood Test
View Press Release
April 17, 2023
GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research Annual Meeting 2023
View Press Release
April 11, 2023
GRAIL Showcases Methylation Platform Performance Across Cancer Continuum with New Data at American Association for Cancer Research (AACR) Annual Meeting
View Press Release
Displaying 31 - 40 of 78